This research aims to explore the treatment approaches for pediatric hepatitis C in a Florida context.
Clinical trials funded by AbbVie, Gilead, and Merck
Assessment of treatment outcomes in children with Hepatitis C
Conflicts of interest disclosed by the lead researcher
Funding sources involved in hepatitis C treatment studies
Abstract
Regino P. Gonzalez-Peralta has received research funding from AbbVie, Gilead, and Merck for clinical trials related to Hepatitis C. The remaining authors declare no conflicts of interest.